Publications by authors named "I Lauschner"

Claim this Profile
W
Weekly administration of bendamustine as salvage therapy in metastatic breast cancer: final results of a phase II study.
Michael H R Eichbaum, Florian Schuetz, Tanja Khbeis, Ilka Lauschner, Frank Foerster

Anticancer Drugs· September 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and pharmacokinetics of bivatuzumab mertansine in patients with CD44v6-positive metastatic breast cancer: final results of a phase I study.
Ute Rupp, Eva Schoendorf-Holland, Michael Eichbaum, Florian Schuetz, Ilka Lauschner

Anticancer Drugs· April 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Doxorubicin/pemetrexed followed by docetaxel versus doxorubicin/ cyclophosphamide followed by docetaxel as neoadjuvant treatment for early-stage breast cancer: a randomized phase II trial.
Andreas Schneeweiss, Ilka Lauschner, Amparo Ruiz, Angel Guerrero, Pedro Sánchez-Rovira

Clin Breast Cancer· April 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dose-dense primary systemic chemotherapy with gemcitabine plus epirubicin sequentially followed by docetaxel for early breast cancer: final results of a phase I/II trial.
Andreas Schneeweiss, Florian Schuetz, Christian Rudlowski, Meinhard Hahn, Ilka Lauschner

Anticancer Drugs· October 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Micrometastatic bone marrow cells at diagnosis have no impact on survival of primary breast cancer patients with extensive axillary lymph node involvement treated with stem cell-supported high-dose chemotherapy.
A Schneeweiss, I Diel, M Hensel, S Kaul, H-P Sinn, I Lauschner

Ann Oncol· November 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis